Guided Therapeutics Inc (GTHP) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access GTHP Annual Balance Sheets →
The balance sheet data below highlights changes in Guided Therapeutics Inc's financial position over recent quarters.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & Short-term Investments0.00
Accounts receivable0.00
Inventories0.50
Other Current Assets0.02
Total Current Assets0.53
Equipment/Property/Plant Net1.62
Other Assets, Noncurrent0.00
Total Assets1.20
Liabilities
Accounts Payable, Current AC2.35
Accrued Liabilities, Current AC1.24
Derivative Liability, Current DE0.04
Notes Payable, Current NO0.04
Other Liabilities, Current2.18
Deferred Revenue, Current DE0.33
Total Current Liabilities6.17
Long-term debt0.05
Total Long-term Debt0.05
Other liabilities, Noncurrent0.74
Operating Lease Liability Current0.06
Total Liabilities6.96
Stockholders' Equity
Common Stock Value3.48
Additional Paid In Capital Common Stock148.84
Retained Earnings / Accumulated Deficit-158.67
Other Equity0.00
Common Stockholder's Equity-5.76
Preferred Stockholder's Equity0.00
Total Stockholder's Equity-5.76
Liabilities & Stockholder's Equity1.20
4 historic quarters locked

Sign in to unlock the full Guided Therapeutics Inc balance sheet history.

About Guided Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 13, 2026
  • Source: gthp_10q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001477932-26-004958

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.